Thyropath
Thyropath is an FDA drug label for the active ingredient AVENA SATIVA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CHELIDONIUM MAJUS, FERRUM IODATUM, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, IODIUM, KALI IODATUM, PHOSPHORICUM ACIDUM, PITUITARUM POSTERIUM (BOVINE), PYRIDOXINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), ZINCUM METALLICUM manufactured by Energetix Corporation administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20260811.
- Generic name
- AVENA SATIVA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CHELIDONIUM MAJUS, FERRUM IODATUM, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, IODIUM, KALI IODATUM, PHOSPHORICUM ACIDUM, PITUITARUM POSTERIUM (BOVINE), PYRIDOXINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), ZINCUM METALLICUM
- Manufacturer
- Energetix Corporation
- Product type
- HUMAN OTC DRUG
- Route
- ORAL
- Dosage form
- N/A
- NDC
- 64578-0133
- Application
- N/A
- Label effective
- 20260811
About this product
Thyropath is an FDA-registered drug product whose active ingredient is AVENA SATIVA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CHELIDONIUM MAJUS, FERRUM IODATUM, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, IODIUM, KALI IODATUM, PHOSPHORICUM ACIDUM, PITUITARUM POSTERIUM (BOVINE), PYRIDOXINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), ZINCUM METALLICUM. It is labelled by Energetix Corporation taken by oral and marketed as a human otc drug product. Identifiers on file: NDC 64578-0133, label effective 20260811. This page reproduces the FDA-approved label text so you can check what a product is, who makes it and how it is supplied before discussing it with a pharmacist or prescriber.
What it is used for
Across FDA labelling, products containing AVENA SATIVA, BORAGO OFFICINALIS, CALCAREA CARBONICA, CHELIDONIUM MAJUS, FERRUM IODATUM, FUCUS VESICULOSUS, GLANDULA SUPRARENALIS SUIS, HEPAR SUIS, IODIUM, KALI IODATUM, PHOSPHORICUM ACIDUM, PITUITARUM POSTERIUM (BOVINE), PYRIDOXINUM HYDROCHLORICUM, THYROIDINUM (BOVINE), ZINCUM METALLICUM are most often described in connection with: temporary relief, fatigue dry, skin restless. Wording differs between labels, and the full indications section on this page takes precedence when it is present.
Active ingredients
Indications & Usage
Uses Temporary relief of fatigue, dry skin, restless sleep.
Dosage & Administration
Directions Take 30 drops orally twice daily or as directed by a healthcare professional. Consult a physician for use in children under 12 years of age or if symptoms worsen or persist.
Warnings
Warnings In case of overdose, get medical help or contact a Poison Control Center right away. If pregnant or breast-feeding , ask a healthcare professional before use. Keep out of reach of children.
Frequently asked questions
What is Thyropath used for?
Uses Temporary relief of fatigue, dry skin, restless sleep.
Who makes Thyropath?
Energetix Corporation is the labeler of record for Thyropath.
What form does Thyropath come in?
administered by oral. Strengths and pack sizes vary by label, so compare the NDC on your pack with the identifier listed on this page.
Is Thyropath prescription or over-the-counter?
The FDA label for this product is recorded as human otc drug. Marketing status can differ between strengths and countries, so check the dispensing rules where you live.
Has Thyropath been recalled?
No FDA recall record in our database matches this product name or manufacturer. Recall data is updated periodically, so a very recent notice may not appear here yet.
Where does this information come from?
All content is reproduced from FDA Structured Product Labelling data via openFDA. It is provided for identification and reference only and is not medical advice.
This page reproduces FDA Structured Product Labelling data for identification and reference. It is not medical advice, does not diagnose or treat any condition, and does not sell or price any medicine.